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Multipotent mesenchymal stem/stromal cells (MSCs) exhibit great potential for cellbased therapy. Proper epigenomic signatures in MSCs are important for the
maintenance and the subsequent differentiation potential. The DNA methyltransferase
3-like (DNMT3L) that was mainly expressed in the embryonic stem (ES) cells and the
developing germ cells plays an important role in shaping the epigenetic landscape.
Here, we report the reduced colony forming ability and impaired in vitro osteogenesis
in Dnmt3l-knockout-mice-derived MSCs (Dnmt3l KO MSCs). By comparing the
transcriptome between undifferentiated Dnmt3l KO MSCs and the MSCs from the wildtype littermates, some of the differentially regulated genes (DEGs) were found to be
associated with bone-morphology-related phenotypes. On the third day of osteogenic
induction, differentiating Dnmt3l KO MSCs were enriched for genes associated
with nucleosome structure, peptide binding and extracellular matrix modulation.
Differentially expressed transposable elements in many subfamilies reflected the change
of corresponding regional epigenomic signatures. Interestingly, DNMT3L protein is not
expressed in cultured MSCs. Therefore, the observed defects in Dnmt3l KO MSCs are
unlikely a direct effect from missing DNMT3L in this cell type; instead, we hypothesized
them as an outcome of the pre-deposited epigenetic signatures from the DNMT3Lexpressing progenitors. We observed that 24 out of the 107 upregulated DEGs in
Dnmt3l KO MSCs were hypermethylated in their gene bodies of DNMT3L knock-down
ES cells. Among these 24 genes, some were associated with skeletal development or
homeostasis. However, we did not observe reduced bone development, or reduced
bone density through aging in vivo. The stronger phenotype in vitro suggested the
involvement of potential spreading and amplification of the pre-deposited epigenetic
defects over passages, and the contribution of oxidative stress during in vitro culture. We
demonstrated that transient deficiency of epigenetic co-factor in ES cells or progenitor
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cells caused compromised property in differentiating cells much later. In order to facilitate
safer practice in cell-based therapy, we suggest more in-depth examination shall be
implemented for cells before transplantation, even on the epigenetic level, to avoid
long-term risk afterward.
Keywords: epigenetics, DNMT3L, DNA methylation, bone-marrow MSCs, osteogenesis

INTRODUCTION

therapeutic properties under culture conditions. MSCs cultured
for prolonged periods or isolated from elder individual are
less efficient in their trilineage differentiation ability, with
the impairment in osteogenesis being particularly significant
(Digirolamo et al., 1999; Bonab et al., 2006; Zhou et al., 2008;
Yang, 2018). Optimization of culture conditions can sustain
MSC properties better in vitro (Sotiropoulou et al., 2006), and
make them safer and more suitable for clinical applications.
These include the introduction of better culture surface (Engler
et al., 2006; Lee et al., 2017), hypoxia condition (Wang et al.,
2020), providing scaffold and other biomaterials (Meinel et al.,
2004; Marrelli et al., 2016), to maintain better multipotency
or differentiation outcome for the cultured MSCs. In addition,
the replacement of FBS by chemically defined or standardized
supplements (Bieback et al., 2009; Marrazzo et al., 2016) can
facilitate the clinical-grade production of MSCs.
While the culture condition can be optimized to certain
extent, the intrinsic defects from the isolated MSCs cannot
be easily fixed. Here we report an unexpected observation
of compromised osteogenesis differentiation ability of MSCs
isolated from DNMT3L deficient mutant mice. DNMT3L is a
germ and ES cell enriched epigenetic cofactor (Bourc’his et al.,
2001; Hata et al., 2002; Liao et al., 2014). We and others
have demonstrated that DNMT3L maintains the quiescence
of spermatogonial progenitor cells and prevents exhaustion of
stem cell populations to maintain male germ line homeostasis
(Bourc’his and Bestor, 2004; Liao et al., 2014). Dnmt3l knockout mice are infertile (Bourc’his and Bestor, 2004; Webster
et al., 2005; Hata et al., 2006), but otherwise develop normally
into adulthood without reported somatic phenotypes. DNMT3L
does not have enzymatic activity but interacts with DNMT3A
and DNMT3B to facilitate de novo DNA methylation and thus
influences gene expression (Chedin et al., 2002; Guenatri et al.,
2013). DNMT3L binds to histone H3 tails in a H3K4methylation
sensitive manner, and recruits other histone modifiers through its
PHD domain (Aapola et al., 2000; Ooi et al., 2007; Otani et al.,
2009; Hashimoto et al., 2010; Zhang et al., 2010). We further
demonstrated that ectopic DNMT3L expression can promote the
assembly of the HDAC1/TRIM28/SETDB1/DNMT3A/DNMT3L
complex and repress transcription of newly infected retroviral
sequence independent of DNA methylation (Kao et al., 2014).
There has been very limited description of potential DNMT3L
functions beyond germ lines and ES cells, partly due to the
difficulties in demonstrating its expression in specific progenitor
cell types in somatic lineages.
Recently we demonstrated that transient expression of
ectopic DNMT3L in later passaged MEFs were sufficient
to cause long term epigenomic landscape changes and halt
senescence progression (Yu et al., 2020). The transiently

Stem cells that are capable of self-renewal and differentiation,
play very important roles to maintain dynamic but sustainable
tissue homeostasis (Collins et al., 2005). This delicate balance
relies on cooperative interactions between transcription networks
and epigenetic regulations, including DNA methylation, histone
modifications and non-coding RNA-mediated modulation of
gene expression (Reik, 2007; Lunyak and Rosenfeld, 2008;
Bloushtain-Qimron et al., 2009; Atlasi and Stunnenberg, 2017).
Multipotent mesenchymal stem/stromal cells (MSCs) have a
trilineage differentiation ability toward osteoblasts, chondrocytes
and adipocytes (Pittenger et al., 1999). In accordance with
their ability to differentiate into multiple lineages, and having
immunomodulatory function(s), MSCs can be isolated from
various origins, such as bone marrow, adipose tissues (Zuk et al.,
2002), umbilical cord blood (Erices et al., 2000), skeletal muscle
(Young et al., 2001), amniotic fluid (In t Anker et al., 2003),
placenta (Miao et al., 2006), and dental pulp (Lin et al., 2011;
Berebichez-Fridman and Montero-Olvera, 2018; Spagnuolo et al.,
2018). With the long history of successful MSC-containing bone
marrow transplantations, as well as the availability from other
accessible origins like tooth, placenta, umbilical cord blood,
amniotic fluid and adipose tissues, MSCs are one of the top
candidate cell types available for allogenic and autologous cell
therapy in regenerative medicine (Ballini et al., 2017; Han et al.,
2019). The therapeutic potential of MSCs is mainly based on
their ability to modulate immune response (Abdi et al., 2008; Gao
et al., 2016). The strong anti-inflammatory effect and paracrine
activity from their secretory proteins and functional RNAs can be
delivered into remote organs or tissues via extracellular vesicles
(Chen et al., 2019). Preclinical and clinical trials on MSCs based
therapy have been carried out in many countries, in order to
improve the treatment for the injured bone, cartilage, and the
autoimmune diseases.
However, one of the limitations of using MSCs in regenerative
medical applications is their gradual loss of multipotency and
Abbreviations: ARS, alizarin red S; BM-MSCs, bone marrow-derived
MSCs; CFUs, colony forming units; CFU-F, colony forming unit-fibroblasts;
DEGs, differentially expressed genes; DETEs, differentially expressed TEs;
DNMT3L, DNA methyltransferase 3-like; ECM, extracellular matrix; EDTA,
ethylenediaminetetraacetic acid; EMSCs, epiphysis-derived mesenchymal
stem/stromal cells; ES, embryonic stem; FBS, fetal bovine serum; FDR, false
discovery rate; HDAC1, histone deacetylase 1; IACUC, Institutional Animal Care
and Use Committee; KD, knockdown; KO, knockout; MACS, magnetic-activated
cell sorting; MEFs, mouse embryonic fibroblasts; αMEM, modified Eagle’s medium
alpha; MOST, Ministry of Science and Technology; MSCs, mesenchymal stromal
cells; OSF-2, osteoblast-specific factor-2; PCA, principal component analysis; PDT,
population doubling time; PHD, plant homeodomain; POSTN, periostin; RIN,
RNA integrity number; ROI, region of interest; SMI, structure model index; TEs,
transposable elements; TSS, transcriptional start site; WGCNA, weighted gene
co-expression network analysis; WT, wild-type.
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4 (Figure 1C), where we used for the differentiation assay. On
the other hand, at passage 6, Dnmt3l KO EMSCs had reduced
proliferation activity compared to those from wild type animals
(Supplementary Figure 2B). This is consistent with our previous
observations of premature senescence phenotype in cultured
Dnmt3l KO MEFs (Liao et al., 2015), as well as slightly shorter
lifespan for Dnmt3l KO compared to wild type littermates
(data not shown).
In addition to self-renewal property, MSCs are able to
differentiate into osteoblasts, chondrocytes and adipocytes
in vitro upon induction (Caplan, 1991). We quantified calcium
precipitation by ARS staining after 14 days of osteogenic
induction and showed that Dnmt3l-KO-mice-bone-marrowderived MSCs (Dnmt3l KO MSCs), and Dnmt3l KO EMSCs
dramatically lost their osteogenic ability (Figure 1D and
Supplementary Figure 2C). The compromised osteogenic
abilities of Dnmt3l KO BM-MSCs could not be attributed merely
to reduced proliferation activity of cells in the passage used
for differentiation analysis (Figure 1C), which is also indirectly
supported by the reasonable adipogenic ability observed on
these cells (Supplementary Figure 3). It is reported that
aging MSCs favor adipogenic differentiation over osteogenic
differentiation (Infante and Rodriguez, 2018). The severely
compromised osteogenesis and relatively mild adipogenesis
defects are reminiscent of a trend for premature aging event.

expressed DNMT3L facilitated the short-term formation of
DNMT3L-DNMT3A-KAP1-SETDB-HDAC1 complex as well
as guiding them to certain endogenous retroviruses and
retrotransposons to introduce H3K9me3 and reduce histone
acetylation in aging fibroblasts (Kao et al., 2014; Yu et al., 2020).
DNMT3L also interacted with polycomb group members to
facilitate repressive H3K27me3 modifications on certain aging
associated derepressed genes. The long-term repressive histone
modifications and dramatically prolonged cell proliferation still
maintained long after the ectopic DNMT3L is silenced (Yu et al.,
2020). In the current study, we tackled a potential long-term
effect of transient endogenous DNMT3L expression in ES cells
and progenitor cells, associated with cellular property changes of
the Dnmt3l KO mice derived MSCs (Dnmt3l KO MSCs) under
culture condition.
We compared the in vitro CFU-F formation rate, proliferation
and differentiation abilities between MSCs derived from Dnmt3l
KO mice and their WT littermates. Significantly reduced CFUFs and impaired osteogenic ability were observed in Dnmt3l KO
mice derived BM-MSCs as well as in another epiphysis-derived
MSCs (EMSCs) population (Cheng et al., 2012). The molecular
mechanisms associated with this impaired osteogenic ability were
investigated by comparing and contrasting the transcriptomes of
undifferentiated and differentiating MSCs derived from Dnmt3l
KO mice and their WT littermates. The injury repair ability of
the endogenous MSCs between wild type and Dnmt3l KO mice
were also compared. As the canonical DNMT3L protein was not
detectable in cultured MSCs, various hypotheses were proposed
and tested to determine how transiently expressed DNMT3L in
ES cells or subsequent progenitor cells contribute to the longterm effect on the subsequent differentiating cell lineages, and
their adaptation toward in vitro culture conditions.

Lack of Canonical DNMT3L Expression
in MSCs
We observed very strikingly reduced CFU-F and osteogenesis
deficit of MSCs isolated from Dnmt3l KO mice (Figure 1B). The
intuitive explanation could be that DNMT3L is expressed and
plays a direct role in cultured MSCs when the cells are out of
their endogenous niches. However, the expression of DNMT3L in
MSCs has not been documented. We performed strand-specific
RNA sequencing analysis for undifferentiated WT and Dnmt3l
KO MSCs at passage 4, as well as for the differentiating cells of the
two genotypes 3 days after osteogenic induction. We confirmed
that Dnmt3l was not expressed in Dnmt3l KO MSCs. However,
low levels of Dnmt3l associated sequences could be identified
from undifferentiated and differentiating wild type BM-MSCs
(Figure 2A). Interestingly, all of the Dnmt3l RNA sequences
from WT MSCs mapped to exon 9a onward, missing exons 1–8
(Figure 2A). The absence of exons 1–8 and the presence of exon
9a–10–11–12–13 of the Dnmt3l transcript in WT BM-MSCs were
supported by our RT-qPCR analysis with various primer pairs
(data not shown). Three alternative transcripts of Dnmt3l starting
from exon 9b were described during sperm development (Shovlin
et al., 2007). However, a potential isoform starting from exon 9a
instead of exon 9b has not been previously described.
On the protein level, we could not detect the canonical
∼50 kDa DNMT3L protein (Figure 2B), consistent with the
lack of RNA expression from exons 1–8. Neither could we
detect distinct immunoblotting signals of the estimated 126-AAlong protein from the possible Dnmt3l isoform starting from
exon 9a (Figure 2C). We have not excluded the possibility
that this exon 9a initiated Dnmt3l RNA isoform may have a

RESULTS
Multipotent MSCs Derived From Dnmt3l
KO Mice Have Reduced Colony Forming
Capacity and Osteogenic Potential
Suggesting Compromised Potency
in vitro
Multipotent MSCs are capable of self-renewal and can
differentiate into multiple lineages in vitro. We compared
and contrasted BM-MSC properties between Dnmt3l KO mice
and their WT littermate. We did not detect differences in
the frequency of MSC cell surface markers tested between
genotypes (Supplementary Figure 1). A significantly reduced
CFU-F was observed from BM-MSCs and EMSCs (another
subtype of MSCs derived from epiphysis from Dnmt3l KO
mice than those obtained from WT littermates (Figures 1A,B
and Supplementary Figure 2A). To clarify whether Dnmt3l
KO MSCs and EMSCs have an overall lower proliferation
activity, or just proliferate poorly in low density, we checked
the proliferation curves of BM-MSCs and EMSCs from paired
Dnmt3l KO mice and wild type littermates. We did not observe
major proliferation differences from paired BM-MSCs at passage
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FIGURE 1 | Dnmt3l KO BM-MSCs have significantly reduced CFU-F forming rate and impaired osteogenic potential. (A) Dnmt3l KO and wild type MSCs at passage
4 were seeded at 1000 cells per well or 2000 cells per well density on 6-well plate, and calculate the colony forming unit-fibroblasts (CFU-F) number after 9 days of
culture. Two batches of independent studies with mixed BM-MSCs from three mice of each genotype were shown. (B) The bar chart shows CFU-F from WT and
Dnmt3l KO mice. The CFU-F with diameter greater than 2 mm were considered valid. (C) MSCs expanded from passage 3 to 4 were seeded at a density of 2 × 104
cells per well in 12 well plates. Cells from three wells of each genotype were isolated each day for 11 days and were calculated for live cell numbers based on trypan
blue dye exclusion. (D) MSCs expanded from passage 3 to 4 were seeded at 5 × 104 cells per cm2 for each well in 6-well plates. Cells were cultured in osteogenic
induction medium once confluence was reached. After 14 days of osteogenic induction, calcium precipitation was quantified by alizarin red S staining. The
osteogenic ability was dramatically decreased in MSCs derived from Dnmt3l KO mice compared to that in MSCs obtained from their wild-type littermates. The data
are presented as the means ± SEM. *p < 0.05, **p < 0.01.

function. Our preliminary RT-qPCR data demonstrated higher
Dnmt3l expression from the 30 -end exons in EMSCs than
in BM-MSCs, associated with more severe potency defects in
Dnmt3l EMSCs.

WGCNA, an unbiased and unsupervised analysis that identifies
modules corresponding to clusters of co-expressed transcripts
among multiple transcriptomes. The results showed two major
gene modules (Figure 3A, marked by turquoise and blue). The
first module contains 928 genes enriched in “cell, morphogenesis
and stem cell differentiation” by gene ontology analysis. The
second module has 898 genes that are specifically associated
with “the maintenance of DNA methylation.” In addition, PCA
revealed four distinct groups signifying that cell differentiation
and Dnmt3l genotype contribute to significant transcriptome
changes (Figure 3B).
In addition to global gene expression patterns observed by
PCA, DEG (at least log2 fold change > 1 with FDR < 0.05)

Transcriptome Analysis of
Undifferentiated and Differentiating
MSCs Derived From Dnmt3l KO Mice
Compared to Those of Wild-Type
Littermates
In order to gain insight into the mechanistic significance of the
in vitro osteogenesis defects in Dnmt3l KO MSC, we performed
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FIGURE 2 | The ∼50 kDa canonical stem cell form of DNMT3L protein is not detectable in MSCs. (A) No sequencing reads were mapped to exons 1–8 of Dnmt3l
suggesting no canonical ∼50 kDa DNMT3L expression in MSCs. However, a potential novel isoform of Dnmt3l transcript starting from exon 9a can be observed to
be expressed in low level in wild type but not Dnmt3l KO mice derived BM-MSCs. In contrast, 3 Dnmt3l isoforms that were described in adult testes previously all
starting from exon 9b. (B) The canonical stem cell form of ∼50 kDa DNMT3L expression is highly expressed in ES cells detected by Western blotting. However, even
under overexposure, there were no detectable DNMT3L signals at early passage (P2, P3, and P4) of MSCs. (C) Possibility of small DNMT3L (estimated to be 126 AA
of around 20 kDa) expression has not been excluded but no distinct bands may be observed from our Western analysis of the MSC samples.

between undifferentiated and differentiating MSCs, or between
different Dnmt3l genotypes of the same differentiation stage,
were indicated in the dendrogram (Figure 3C). In Figure 3C,
each row presents a DEG. Approximately 300 genes (Figure 3C,
DEG_wt_d3lKO_un group) were differentially expressed in
Dnmt3l KO MSCs in the undifferentiated state, of which 106
were upregulated and 202 were downregulated. These DEGs
were highly correlated to receptor binding, cytokine activity,
cargo receptor activity, and ECM structural constituent, which
may directly or indirectly influence the MSC differentiation
potential upon induction of differentiation (Figure 3D). In
addition, some of these DEGs were overlapped with signature
genes associated with bone related phenotypes as summarized
in the MGI mammalian phenotypes database (Table 1). For
example, Postn encodes the matricellular protein POSTN, which
is downregulated in Dnmt3l KO MSCs. Postn is transcriptionally
activated by RUNX2 in the MC3T3-E1 osteoblast precursor
cell line, suggesting that POSTN, also known as OSF-2, is

Frontiers in Cell and Developmental Biology | www.frontiersin.org

involved in early osteoblast development (Stock et al., 2004).
This gene is highlighted in the categories of abnormal long
bone morphology (MP:0003723), short femur (MP:0003109), and
short tibia (MP:0002764). Previous studies also demonstrated
that POSTN may play a crucial role in bone formation and
homeostasis (Bonnet et al., 2012; Merle and Garnero, 2012;
Zhang et al., 2017), which is highly correlated to the jeopardized
osteogenic differentiation ability observed in Dnmt3l KO MSCs.
Upon comparing transcriptomes of MSCs derived from
Dnmt3l KO and WT mice after 3 days of induction toward
osteogenesis, a more significant change was observed (n = 567
DEGs, 239 genes were upregulated and 328 genes were
downregulated) (Figure 3C, DEG_wt_d3lKO_D group). We
noticed a clear enrichment of these DEGs in molecular binding
related properties, including nucleosome and nucleosomal DNA,
peptide, kinetochore, odorant, and collagen binding, as well as
genes associated with general molecular function regulation. In
addition, with enrichment of DEGs in GO terms associated
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FIGURE 3 | Analyses of Dnmt3l genotype-specific differentially expressed genes (DEGs) in undifferentiated and differentiating MSCs on day 3 of osteogenic
induction. (A) Weighted correlation network analysis was performed, with the two major gene modules marked in turquoise and blue. The first (turquoise block)
module contains 928 genes enriched in cell, morphogenesis and stem cell differentiation. The other module has 898 genes that are categorized as maintenance of
DNA methylation. (B) Principal component analysis (PCA) of gene expression. (C) Each row represents a DEG. Four groups of DEGs are shown on the left and
marked in green. Most DEGs highlight the transition during differentiation. There are also differences between the WT and Dnmt3l KO MSCs, indicating the
contribution of DNMT3L to these differences. The heatmaps illustrate the expression patterns of genes that are modulated by either differentiation or the DNMT3L
effect. DEG_wt_d3l_un: DEGs between WT and Dnmt3l KO in undifferentiated MSCs; DEG_wt_d3lKO_D: DEGs between WT and Dnmt3l KO in differentiating
MSCs; DEG_D_un_wt: DEGs between undifferentiated and differentiating MSCs derived from WT mice; and DEG_D_un_d3lKO: DEGs between undifferentiated and
differentiating MSCs in Dnmt3l KO mice-derived MSCs. (D) Gene ontology analysis of DEGs between WT and Dnmt3l KO undifferentiated MSCs. (E) Gene ontology
analysis of osteogenic differentiating (day 3 of osteogenic induction) DEGs between WT and Dnmt3l KO MSCs. All GO terms presented on the bubble plots have an
adjusted p-value of <0.05.
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To investigate whether DNMT3L-dependent gene expression
patterns carry over from ES cells to MSCs, DEGs from an
expression array of ES cells were compared to MSC RNASequencing data. Only 4 out of 309 genes were differentially
expressed in the Dnmt3l KD ES cells and undifferentiated Dnmt3l
KO MSCs (Figure 4C), and 7 out of 567 DEGs were identified
in differentiating MSCs (Figure 4D), indicating that the role
of DNMT3L legacy from ES cells on MSC properties is not a
primary effect in gene expression.
DNMT3L is a well-known epigenetic cofactor, functioning
within the de novo DNA methylation machinery. With the
faithful memory of DNA methylation after cell division,
alterations in Dnmt3l genotype-dependent DNA methylation
level in ES cells could therefore be one of the most promising
long-lasting epigenomic marks that are potentially responsible
for the compromised Dnmt3l KO MSCs properties. To
understand the influence of DNMT3L on DNA methylation,
we analyzed the DNA methylation patterns of WT and Dnmt3l
KD ES cells. According to the metagene plots, the methylation
of Dnmt3l KD ES cells was generally higher than WT cells
around genes, particularly at the promoter region (Figures 4E,F),
and the same result was observed in the enrichment analysis
(Figure 4G). We further found that these changes in DNA
methylation occurred in genes from ES are associated with
increased expression (between Dnmt3l KO and WT) in MSC
(Figure 4H), indicating a positive correlation between changes in
DNMT3L-induced methylation in ES cells and gene expression
in MSCs, as a potential signal of DNMT3L legacy.
We further clarified whether the differential gene expressions
in in vitro cultured Dnmt3l KO and WT MSCs, a cell type
no longer expressing DNMT3L, may have association with
DNMT3L-dependent DNA methylation mark in ES cells. Apart
from the epigenomic modulation of regulatory sequences,
DNA methylation on actively transcribed genes, had also been
demonstrated (Bender et al., 1999).
We observed that 24 genes were upregulated in Dnmt3l KO
MSCs and hypermethylated at the gene bodies in Dnmt3l KD ES
cells (Figure 4I and more comprehensive analysis summarized in
Supplementary Figure 6), with a very low p-value < 1.387e-04,
indicating the significant overlap based on the hypergeometric
distribution test. Of the 24 genes, some gene products have been
reported to tie with skeletal development or homeostasis, with
a few of them acting directly in MSCs to regulate osteogenic
differentiation, namely, HIEVP3 and GATA2 inhibiting BMPinduced osteogenesis (Tolkachov et al., 2018; Li et al., 2020),
DLX3 being a negative modulator (Levi and Gitton, 2014), while
FGF18 and Wnt10a providing stimulatory signal (Charoenlarp
et al., 2017; Jing et al., 2018). Those results suggest that the
occurrence of DNMT3L-mediated epigenetic legacy, if any, may
be observed in limited genes in cultured MSCs.

TABLE 1 | MGI mammalian phenotypic identification of undifferentiated DEGs
between wild-type and Dnmt3l KO MSCs by enrichment analysis.
P-value

Adjusted
p-value

Decreased body weight (MP:0001262)

0.001719

0.128

Abnormal macrophage physiology
(MP:0002451)

0.0009388

0.1133

Abnormal long bone morphology (MP:0003723)

0.0003274

0.1133

Short femur (MP:0003109)

0.0004068

0.1133

Short radius (MP:0004355)

0.0002514

0.1133

Abnormal ureter morphology (MP:0000534)

0.0002751

0.1133

Short tibia (MP:0002764)

0.001353

0.1205

Abnormal neuromuscular synapse morphology
(MP:0001053)

0.0005063

0.1133

Decreased placenta weight (MP:0004921)

0.0004709

0.1133

Abnormal forelimb morphology (MP:0000550)

0.0008594

0.1133

with collagen binding, hydrolase activity and ECM structural
constituent, we suggest that MSCs derived from Dnmt3l KO mice
may have suboptimal modulatory activities and responsiveness
toward ECMs (Figure 3E).
With candidate approach, we also have observed the
expression profile of several other bone related biomarkers,
including Sp7, Col1a1 and Col1a2, from our sequencing datasets.
Dnmt3l genotype associated, statistically significant differences
were observed in all of these genes at day 3 of in vitro MSC
differentiation toward osteoblast, while significant differences can
be found in Col1a1 and Col1a2, as well as the aforementioned
Postn genes in MSCs of different Dnmt3l genotype even before
differentiation (Supplementary Figure 4).

Searching for Potential
DNMT3L-Mediated Epigenetic Memory
From ES Cells
Given DNMT3L protein was not detected in MSCs, we explored
the possibility of DNMT3L-mediated epigenetic modulation in
pluripotent stem cells; we hypothesized that the DNMTs may
exhibit a long term effect that could alter the differentiation
potential of the cultured MSCs in vitro. We re-analyzed publicly
available DNMT3L ChIP-Seq (GSE49178), DNMT3L KD ES
cells gene expression array (GSE44643) and MeDIP sequencing
(GSE44642) data (Neri et al., 2013).
To understand which genes are directly regulated by
DNMT3L, we categorized DNMT3L binding sites in gene bodies,
promoters or repeat sequences from DNMT3L ChIP-Seq data
from ES cells. We observed that DNMT3L binding sites were
enriched in 50 -UTRs, coding regions and TEs (Figure 4A). To
verify the lasting impact of DNMT3L from ES cells to MSCs, we
first sought to identify the overlap between DNMT3L binding
sites in ES cells and DEGs between the WT and Dnmt3l KO
MSCs. However, in both undifferentiated and differentiating
MSCs, only 11 Dnmt3l genotype associated DEGs were also
associated with DNMT3L binding in ES cells (Figure 4B and
Supplementary Figure 5); suggesting most DEGs in MSCs were
not the direct targets of DNMT3L in ESCs.
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activity of DNMT3L (Bourc’his and Bestor, 2004), we
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FIGURE 4 | Possibility of DNMT3L-mediated legacy and the DNA methylation level contributing to the compromised self-renewal and differentiation potential of
Dnmt3l KO MSCs. (A) Enriched DNMT3L binding in ES cells is observed in the 50 UTR and coding region of coding genes. (B) Only 11 out of 308 DEGs between
undifferentiated MSCs derived from WT and Dnmt3l KO mice are direct DNMT3L binding targets in ES cells. (C) Only four genes are differentially expressed in both
ES cells and undifferentiated MSCs between the WT and Dnmt3l mutant cells (Dnmt3l KO MSCs and Dnmt3l KD ESCs); (D) Only seven genes are differentially
expressed in both ES cells and differentiating MSCs between WT and Dnmt3l mutants. (E) DNA methylation level in WT and Dnmt3l KD ES cells are profiled for all
genes as well as their immediate upstream and downstream regions. (F) The methylation regions in Dnmt3l KD ES cells are enriched in the 50 UTR and coding
sequence. (G) Differential gene methylation between WT and Dnmt3l KD ES cells. Greater enrichment on TEs in WT ES cells are observed, indicating that DNMT3L
facilitates de novo methylation in these sequences. (H) The difference in gene methylation between WT and Dnmt3l KD in high/low expression genes. (I) Twenty-four
out of 107 genes upregulated in Dnmt3l KO MSCs are overlapped with hypermethylated genes in ES cells with Dnmt3l knock down. The p-value calculated by
hypergeometric test is very low, indicating that these 24 up-regulated genes in Dnmt3l KO MSCs are not due to random overlapping in highly methylated ES cells.
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Circadian disruption has been associated with metabolism defect
and aging-like phenotype (Sato et al., 2017). With the combined
jet-lag paradigm and high fat diet treatment, we no longer
observed Dnmt3l genotype specific differences in bone properties
(Supplementary Figure 9). We concluded that Dnmt3l KO male
mice have stronger response to lifestyle intervention-induced
trabecular bone mass reduction.

assessed the possibility of correlating specific families of
deregulated TEs to the impaired properties of Dnmt3l KO
MSCs. The DETEs with four-fold changes were subjected to
unsupervised heat map analysis (Supplementary Figure 7A).
Genotype-dependent differences (four-fold changes) were
manifested in an undifferentiated but not at differentiating
state based on PCA analysis (Supplementary Figure 7B).
Even without considering vast copy numbers of each TE
sequences, there are more DETEs between WT and Dnmt3l
KO genotypes in undifferentiated MSCs than the number of
DEGs (Supplementary Figure 7C). DETEs populated in specific
subfamilies such as DNA transposon, LINE, SINE and LTR,
suggesting the accumulative effects from DNMT3L targeting
these four subfamilies of TEs (Figure 5A). The significant
reduction of upregulated TEs from undifferentiated Dnmt3l
KO MSCs across many TE families (blue bars from Figure 5A)
indicated possible epigenomic signature changes across many
genomic loci from this cell type. In the differentiating MSCs,
DETEs were enriched in the subfamilies of DNA transposon
(hAT-Tip 100), LINEs (L2 and CR1), SINE (B4) and ERVK of the
LTR family (green and purple bars in Figure 5A).
With the known property of DNMT3L in TE modulation,
we also analyzed the profile of DNMT3L associated DNA
methylation marks from ES cells in relation to TE expressions
in cultured MSCs of different Dnmt3l genotype. The DNA
methylation is relatively low at most TE regions in ES cells.
Dnmt3l KD induced further reduction was particularly enriched
in LINE and LTR retrotransposons in ES cells (Figures 5B,C).
In addition, we investigated the potential role of Dnmt3l in
undifferentiated and differentiating MSCs using differentially
expressed analyses of TEs. The direct correlation between
changes in DNA methylation and gene expression of TEs
(Figure 5D) did not provide clear evidence of an association in a
specific direction. However, our results displayed that the change
of global epigenomic landscapes are associated with the altered
expression of TEs. These affected TEs or their neighboring genes
in Dnmt3l KO MSCs may contribute to the observed osteogenesis
defect phenotype in vitro.

DISCUSSION
Mesenchymal stem/stromal cells hold promises for regenerative
medical applications either by cell transplantation directly or by
applying their secretory products (Madrigal et al., 2014; Han et al.,
2019). In vitro amplification is needed for most of these practices.
Various advancements have made to maintain and amplify
MSCs in culture condition (Sotiropoulou et al., 2006). However,
genotype effect cannot be easily fixed. Apart from infertility,
Dnmt3l KO mice does not cause any other obvious defects. It is
therefore a surprise for us to see obvious osteogenesis impairment
of MSCs derived from Dnmt3l KO in this current study, especially
when DNMT3L protein expression cannot be detected in these
cell type. Although we cannot exclude the possibility that a small
population of MSCs may express Dnmt3l, it is notable that the
impaired CFU-F forming and osteogenic activities occurred in
global population of MSCs and not the small population of
Dnmt3l-expressing MSCs. The current study also identified a
potential novel isoform of Dnmt3l transcript starting from exon
9a. Our preliminary RT-qPCR data suggested higher expression
from the 30 -end of Dnmt3l in EMSCs than in BM-MSCs,
associated with more severe potency defects in Dnmt3l EMSCs.
The possibility for this partial transcript of Dnmt3l exon 9a
onward being functional could not be excluded at this stage.
However, it is still more plausible that the differences in the
cultured MSCs was due to an accumulative cellular memory predeposited in DNMT3L expressing progenitor cells. DNMT3L
is predominantly expressed in ES cells. We have recently
demonstrated that transient ectopic DNMT3L expression in
fibroblast is sufficient to introduce long-term effect on epigenome
and cell proliferation property, over 40 passages after the ectopic
DNMT3L is silenced (Yu et al., 2020), speculating that transiently
expressed DNMT3L in ES cells or other progenitor cells, may
also have long lasting effects that protect MSCs from premature
senescence. The hypothesis of “DNMT3L-mediated epigenetic
legacy” (Figure 6) assumes that DNMT3L sustains a normal
epigenome or gene expression profile in ES cells. Without
DNMT3L expression in the pluripotent stem cells of Dnmt3l
KO preimplantation embryos, some of the aberrant epigenetic
signatures may be carried over to somatic progenitor cells, and
therefore compromising the property of Dnmt3l KO MSCs under
in vitro culture and differentiation condition. When comparing
DNMT3L binding sites and DNMT3L associated gene expression
pattern and methylation status in ES cells, with the DEGs
between MSCs from Dnmt3l KO and wild type littermates. There
is no strong correlation between DNMT3L bound regions or
DNMT3L associated DEGs in ES cells, with Dnmt3l genotype
related DEGs in MSCs. Interestingly, DNA methylation at the

Bone Morphology Analysis in vivo
In contrast to the strong osteogenesis defects in vitro, we did not
observe obvious differences in trabecular bone phenotype in 5months-old Dnmt3l KO females (Supplementary Figure 8). In
23-months-old wild type female mice, we can indeed observe
the aging induced reductions in trabecular number, connectivity
density, percent bone volume, which give higher risk for vertebral
fracture, as well as increase in SMI and reductions in bone
thickness and bone surface density expected for aging mice (Qiu
et al., 2006; Ostertag et al., 2009; Chen et al., 2013). However, we
did not observe the expected osteoporosis related symptoms in
Dnmt3l KO aging female mice. In contrast, a protective effect was
observed in the parameters including connectivity density and
trabecular thickness (Supplementary Figure 8).
In an attempt to induce accelerated aging, we introduced
high fat diet and time-zone shifting model in 6-month-old
Dnmt3l KO male mice and their littermates. The light-dark
cycle was shifted 6 h forward each week, for six times in total.

Frontiers in Cell and Developmental Biology | www.frontiersin.org

9

February 2021 | Volume 9 | Article 615098

Yang et al.

Dnmt3l-Knockout MSCs Fail Osteogenesis in vitro

FIGURE 5 | Dnmt3l genotype associated differential TE expressions and DNA methylation levels in MSCs. (A) Significant changes of TE expression patterns were
observed in Dnmt3l- / - undifferentiated and differentiating MSCs, compared to wild type MSCs. Blue, upregulated TEs in undifferentiated Dnmt3l KO MSCs, UP (Un).
Brown, downregulated TEs in undifferentiated Dnmt3l KO MSCs, Down (Un). Green and purple indicate upregulated and downregulated TEs in differentiating MSCs
at day 3 of osteogenesis induction, UP (Day3) and Down (Day3), respectively. (B) The DNA methylation is obvious low at TE regions in ES cells. In addition to repeat
sequences, DNMT3L binding regions are mostly enriched in satellites in ES cells. (C) DNMT3L associated differentially methylated TEs in ES cells (D) Blue dots
indicate Dnmt3l KO genotype associated differentially expressed TEs in undifferentiated MSCs (left); Green dots indicate Dnmt3l KO genotype associated differentially
expressed TEs in differentiating MSCs (right); red circled dots indicate differentially expressed TE with a ≥2-fold change in methylation in Dnmt3l KD ES cells.
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FIGURE 6 | Hypothesis of DNMT3L-mediated epigenome legacy from embryonic stem cells influencing MSC properties. We propose that the expression of
DNMT3L in ES cells is essential to maintain the normal epigenome. Some of these DNMT3L associated epigenomic landscape may be carried over all the way from
pluripotent stem cells to influence isolated MSC properties from adult mice, and their self-renewal and differentiation abilities in vitro.

Dnmt3l KO MSCs, associated to the deregulation of methylation
landscape in Dnmt3l KD ESCs, indirectly support this notion.
The serious loss of osteogenesis ability and retained
adipogenesis ability of the cultured Dnmt3l KO MSCs out
of their endogenous niche resembled the tilted osteogenesis to
adipogenesis balance of aging MSCs (Yang et al., 2018). Several
mechanisms may simultaneously contribute to MSC aging and
senescence related phenomena, including telomere shortening,
mitochondrial dysfunction resulting from oxidative stress, the
accumulation of DNA damage, and genome wide shifting of
the epigenetic modification landscape (Li et al., 2017). Whereas
the physiological oxygen level in healthy human bone marrow
is approximately 7.5% (Harrison et al., 2002; Jagannathan
et al., 2016), conventional cell culture systems use roughly 19%
oxygen, which may pose oxidative stress to MSCs, leading to
mitochondrial dysfunction and cellular senescence. Indeed,
recent studies indicated that hypoxic conditions (1% oxygen)
prevent MSCs from entering senescence via the HIF-1α pathway
(Tsai et al., 2011). However, osteogenesis may be inhibited under
this extreme hypoxic condition (Yang et al., 2011). Interestingly,
MSCs consume more oxygen for increased mitochondrial
oxidative phosphorylation and exhibit downregulated levels of
HIF-1α during osteogenesis, whereas glycolysis activity remains
consistent (Shum et al., 2016). It has been shown that HIF-1α
requires pyruvate for cancer cells under aerobic conditions
(Lu et al., 2002). Accordingly, we observed that the levels of
glyceraldehyde 3-phpsphate dehydrogenase (GAPDH), a key
player in pyruvate metabolism of glycolysis, drastically fluctuate
between undifferentiated and differentiating MSCs (data not
shown) despite culturing MSCs under 19% oxygen and with
pyruvate. Although the detailed mechanisms for the failure of
osteogenic induction in Dnmt3l KO MSCs require much further
study, it is possible that metabolic defect could be one of the
legacies pre-deposited from DNMT3L-expressing progenitors.

gene body and promoter regions is most affected in Dnmt3l
KD ES cells. Our results showed that gene bodies contain the
most overlapped targets, with the effect of DNA methylation
potentially carried over from ES cells into MSCs (Figure 4I).
Among the 107 DEGs between undifferentiated Dnmt3l KO and
wild type MSCs, 24 bears DNMT3L associated DNA methylation
on their gene bodies in ES cells. Several of these 24 genes
have direct or indirect implications in bone morphogenesis
or homeostasis. For example, HIVEP3 (also called Schnurri-3,
Shn3) inhibits BMP9-induced osteogenic differentiation from
human amniotic MSCs (Tolkachov et al., 2018; Li et al.,
2020), and GATA2 is implicated in interfering BMP2-induced
SMAD signaling and thus inhibiting osteoblast differentiation
demonstrated by an ectopic expression experiment (Tolkachov
et al., 2018; Li et al., 2020). FGF18 stimulates rat and mouse
MSCs for their osteogenic differentiation (Charoenlarp et al.,
2017; Jing et al., 2018). DLX3 serves as a negative regulator of
osteogenesis and contributes to bone homeostasis with other
transcription factors, such as DLX5 (Levi and Gitton, 2014).
Also, Cyp26b1 has effect in osteoblast and Cxcl5 functions
for mobilizing HSC away from BM. Although these last two
factors may not directly contribute to the phenotype observed
in our MSC in vitro osteogenesis impairment phenotype, they
provide implications for the miscommunication between the
niche MSCs and the DNMT3L expressing HSCs, the progenitor
of osteoclast cells. Although there are only limited numbers
of genes having correlation between their DNMT3L associated
DNA methylation in ESCs and their Dnmt3l genotype associated
expression patterns in MSCs, the several highlighted genes may
be important enough to contribute in part to the osteogenesis
defects observed. In addition, potential DNMT3L associated
legacy from progenitor cells or niche interacting defects may go
beyond DNA methylation level, and beyond coding genes. The
fact that more TEs related sequences are deregulated in cultured
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effects may even be amplified from spreading of the epigenetic
alternations through excessive cell proliferations in vitro or
in vivo. This is particularly important for the cell-based
regenerative medicine when transient exposure of stem cells
under aberrant condition would have long lasting effect that may
not be perceived before transplantation, but conveying long-term
risk thereafter.

Our ongoing study concerning dietary alteration-associated
effects in paired Dnmt3l KO and WT littermates also shows
similar implications.
Our previous study demonstrated that MEFs derived from
Dnmt3l KO embryos enter senescence prematurely. This
phenomenon is associated with a reduction of suppressive
H3K9me3 and H3K27me3 marks and the premature extrusion
of HDAC1 to the cytoplasm (Liao et al., 2015). On the
other hand, ectopic expression of DNMT3L in aging MEFs
significantly increases the nuclear localization of HDAC1.
In addition, exogenous DNMT3L is sufficient to recruit
DNMT3A/KAP1/SETDB1/HDAC1 to both newly infected
retroviruses and some endogenous retroviruses by inducing
H3K9me3 in aging MEFs (Kao et al., 2014). As non-canonical
bivalent H3K4me3/H3K9me3 signature was observed on
adipogenic determining genes, Cebp-alpha and Ppar-gamma
(Matsumura et al., 2015) in MSC cell line, we looked into whether
the SETDB1-dependent repressive H3K9me3 marks on those
adipogenic master regulator genes accounted for a possible
DNMT3L associated epigenetic legacy in MSCs that prevented
premature determination of adipogenic fate. Although we
have not obtained any conclusion from H3K9me3 ChIP-qPCR
experiments, lacks of Cebp-alpha and Ppar-gamma upregulations
in undifferentiated Dnmt3l KO MSCs or their osteogenic
differentiating derivatives suggest the impaired non-canonical
bivalent mark on adiogenic genes is unlikely the primary reason
behind the titled osteogenesis to adipogenesis balance observed
in Dnmt3l KO MSCs in vitro.
Despite the serious osteogenesis impairment of Dnmt3l KO
MSCs in vitro, counterintuitively, does not correlate to strong
bone formation defects or osteoporosis phenotype in vivo.
One may consider the balance between activities of osteoblasts
and osteoclasts in vivo for the bone density phenotype. Since
DNMT3L has been shown to be expressed in hematopoietic
stem cells (HSCs), the progenitor cells of osteoclasts (Fierro
et al., 2017), DNMT3L deficiency in HSCs may potentially
contribute to reduced osteoclast function and hence the increased
bone density observed in Dnmt3l KO mice. MSCs are also
determined as one of the cell types building HSC niche (Ehninger
and Trumpp, 2011), suggesting potential intercommunication
between these two cell lineages. Interestingly, expression of the
Cxcl5 gene that encodes a chemokine to induce mobilization of
HSC from BM (Yoon et al., 2012) was elevated in Dnmt3l KO
MSCs, whereas expression of the factors for HSC maintenance,
Angpt1 and Cxcl12 were significantly decreased (Supplementary
Table 3). Altogether, in Dnmt3l KO mice, the defective
osteogenesis of MSCs as disclosed in our in vitro study, combined
with the proposed inefficiency of bone breakdown, would give
rise to only subtle, if any, phenotypes in vivo concerning the
bone homeostasis. The in-depth study of DNMT3L function in
HSCs and their derivatives would be another important episode
for understanding the function and properties of this important
epigenomic modulator DNMT3L beyond its highly expressing
pluripotent stem cells and germ cells.
We demonstrated in this study that long term effects on
cell fate and property can be induced by transient expression
or deficiency of epigenetic modifiers and cofactors. These
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MATERIALS AND METHODS
Animals
Due to the infertility phenotype for both male and female Dnmt3l
KO mice, the Dnmt3l+/tmEnls mutant allele was maintained
as heterozygous colony. Dnmt3l KO mice and Dnmt3l+/+
littermate controls were generated from intercrossing mice with
the heterozygous Dnmt3l+/tmEnls mutant allele (Hata et al., 2002)
in a C57BL/6 genetic background. In average, one Dnmt3l−/−
KO mice and one Dnmt3l+/+ littermate control from one gender
were generated from one litter. Female mice (8–16 weeks old)
were euthanized to harvest MSCs for experiments. The care of
mice and the experimental procedures involving animals were
approved by the Institutional Animal Care and Use Committee
(IACUC) of National Taiwan University (approval number NTU104-EL-00031).

Isolation of Mouse Bone Marrow MSCs
For each experiments, we collected bone marrow MSCs from
three Dnmt3l KO mice of the same gender and age, as well as
the counterparts from the three Dnmt3l+/+ littermate controls,
to prepare mixed MSCs from each genotype. The procedure used
to isolate mouse bone marrow MSCs was previously described
(Cheng et al., 2012, 2014; Lee et al., 2017). Briefly, the femur and
tibia were separated from the mouse after euthanasia by quickly
removing the muscle and connective tissue with forceps and
scissors. A 23-gauge needle containing 12 mL of culture medium
[αMEM (Gibco, Grand Island, NY, United States) supplemented
with 20% FBS (HyClone, Logan, UT, United States) and
antibiotics (100 U/mL penicillin and 100 µg/mL streptomycin;
Gibco)] was used to flush out femur bone marrow. A similar
procedure was performed with a 26-gauge needle and 6 mL of
culture medium to acquire tibia bone marrow. The bone marrow
and minced femur and tibia were cultured in 100-mm Petri dishes
(TPP, Trasadingen, CH, Switzerland). After 9 days of culturing
with medium changes every 3 days to deplete non-adherent cells,
adherent cells were detached with 0.25% trypsin/EDTA (Gibco)
for 5 min in an incubator. Cells were then transferred to a 70µm nylon cell strainer (Falcon, Corning, NY, United States) to
remove cell clumps. MSCs were isolated using a MACS system
(Miltenyi Biotec, Teterow, DE, Germany) with CD11b (Miltenyi
Biotec) and CD45 (Miltenyi Biotec) microbead antibody doublenegative selection according to the manufacturer’s protocol to
avoid hematopoietic lineage contamination. Briefly, 107 cells
were resuspended in 10 µL of CD11b antibody, 10 µL of CD45
antibody and 180 µL of MACS running buffer (Miltenyi Biotec),
and the cells were left to react for 15 min at 4◦ C. One microliter of
running buffer was added to stop the reaction, and the cells were
R
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centrifuged for 5 min at 1200 rpm. Subsequently, the supernatant
was removed, and another 1 mL of running buffer was added to
resuspend the cells. A MACS LD column (Miltenyi Biotec) was
inserted into a MidiMACSTM separator (Miltenyi Biotec), and a
collection tube was placed under the column to harvest MSCs.
The column was rinsed with 2 mL of running buffer. Afterward,
the cells were transferred into the column. When the column was
about to dry out, 1 mL of running buffer was added to wash out
unlabeled cells (i.e., non-hematopoietic cells). The procedure was
repeated, and enriched MSCs were harvested from the effluent.
After 5 min of centrifugation at 1200 rpm, running buffer was
removed and replaced with culture medium. MSCs were seeded
at a density of 5 × 104 cells per cm2 .

Osteogenic Differentiation
Osteogenic induction medium was composed of 10%
FBS-αMEM supplemented with 0.1 µM dexamethasone
(Sigma-Aldrich, St. Louis, MO, United States), 10 mM
β-glycerophosphate (Sigma-Aldrich) and 50 µM L-ascorbic
acid 2-phosphate (Sigma-Aldrich) (Jaiswal et al., 1997). For each
sample, 5 × 104 cells per cm2 were seeded into a 6-well plate.
After reaching confluence in 2 days, the cells were incubated with
osteogenic induction medium. The medium was changed every
3 days, and analyses were performed after 14 days of induction.
To assess calcium precipitation, the induction medium was
removed, and the cells were washed once with PBS. Next, the
cells were fixed with 10% formaldehyde (Sigma-Aldrich) for
10 min with gentle shaking, and after another wash with PBS,
the cells were stained with 500 µL of 2% ARS (pH 4.1–4.3)
(Sigma-Aldrich) for 15 min. After extensive PBS irrigation, the
precipitate was dissolved in 500 µL of 10% cetylpyridinium
chloride (Sigma-Aldrich) in 8 mM Na2 PO4 (Sigma-Aldrich) and
1.5 mM KH2 PO4 (Sigma-Aldrich). The absorbance at 550 nm
was recorded, and quantification of calcium was determined
using an optimal ARS standard curve. The optimal dilution
was performed to ensure that the sample absorbance fell within
the standard curve.

R

Isolation of an MSC Subtype:
Epiphysis-Derived Mesenchymal
Stem/Stromal Cells (EMSCs)
The procedure used to harvest the EMSC subtype was based
on our previous report (Cheng et al., 2012). We isolated
the femurs and tibias of mice and thoroughly removed the
adherent soft tissues. The epiphyses were then removed using
shears and rinsing out of any possible bone marrow fluids
with culture medium. The cleaned intact epiphyses (without
mincing) were then transferred to 22.1 cm2 culture dishes
(TPP) and cultured in complete medium composed of MEM
alpha (Sigma-Aldrich) supplemented with 20% FBS (HyClone),
2 mM L-glutamine (100 U/ml penicillin, and 100 µg/ml
streptomycin; Invitrogen). The cells were incubated under a
humidified atmosphere containing 95% air and 5% CO2 at
37◦ C. The non-adherent cells were removed by changing the
medium every 3 days. After 11 days, the primary culture reached
approximately 70% confluence, and the cells were detached with
0.25% trypsin/0.1 mM EDTA (trypsin/EDTA; Invitrogen) for
1 min at 37◦ C. Subsequently, the reaction was stopped by adding
complete medium. The cells that could not be lifted within 1 min
were discarded. The detached cells were centrifuged at 400 × g
for 5 min, resuspended in the complete medium, and subjected
to negative selection using the CD11b and CD45 antibodies as
described in the BM-MSC isolation section above.

RNA Extraction, Library Preparation and
Sequencing
Total RNA was extracted using TRIzol reagent (Invitrogen,
Carlsbad, CA, United States) and a RNeasy mini kit (Qiagen,
Hilden, DE, Germany) following the manufacturer’s instructions.
RNA was treated with DNase 1 (Qiagen) to prevent DNA
contamination. The quality of total RNA was checked using
an Agilent Bioanalyzer 2100 with an Agilent RNA 6000 Nano
Kit, and the RIN of the total RNA samples were all greater
than 8. We used 2.5 µg of total RNA as input for strandspecific RNA library preparation following the removal of rRNA
using a Ribosomal Illumina Ribo-Zero Gold rRNA Removal Kit
(Human/Mouse/Rat) (Illumina, San Diego, CA, United States).
The rRNA-depleted RNA libraries were constructed using an
Illumina TruSeq Stranded mRNA Sample Prep kit following
the user guide at the fragment RNA step. The libraries were
sequenced using an Illumina HiSeq 2500 system with Rapid run
mode (50-bp single-end reads). Each sample was sequenced to
obtain approximately 70.7 M raw reads.

Colony-Forming Unit Assay
One or two thousand cells from passage 3 were seeded into 6well plates (TPP). After 9 days of culture, cells were fixed with
methanol (J. T. Baker, Center Valley, PA, United States) and
visualized by Giemsa stain (Gibco). Colonies greater than 2 mm
in diameter were defined as valid.

RNA-Seq Analysis
The mRNA reads were strand-specifically aligned to the mouse
reference genome (mm10) using Tophat2 (Kim et al., 2013;
Trapnell et al., 2013), with the gene annotation downloaded
from iGenome. The reads per gene counts were generated using
Cuffdiff (Trapnell et al., 2013), which was also used to identify
DEGs between samples using a ≥2-fold change in expression and
a FDR less than 5%. The transposon annotation was downloaded
from UCSC (Karolchik et al., 2004). The expression counts of
transposons were generated using multiBamCov from BEDtools
(Quinlan and Hall, 2010), and a transposon was considered
to be expressed if it was expressed in at least one or more

Cell Growth Assay
The PDT was determined to assess the growth of MSCs. In brief,
Dnmt3l KO MSCs and wild type MSCs from passage 3 were
seeded for 33 wells with a density of 2 × 104 cells per well in
12-well plate. These cells were allowed to adhere for 24 h at
37◦ C under an atmosphere with 95% air and 5% CO2 . Cells
from three wells of each genotype were isolated and evaluated by
trypan blue staining each day for 11 days to calculate the number
of living cells.
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patella and joint were stored in 70% EtOH, and subject to 3D
micro-CT imaging. The area of distal femur 0.4 to 1.9 mm
from growth plate were used to analyze bone density and other
trabecular parameters, with source voltage of 70 kV, source
current of 57 µA, exposure for 1669 ms with AI 0.5 mm filter and
image pixel size of 9 µm. Among the parameters, the elevated
trabecular separation, reduced trabecular number, connectivity
density and percent bone volume are associated with vertebral
fracture (Qiu et al., 2006; Ostertag et al., 2009). On the other hand,
increased SMI, decreased trabecular thickness and bone surface
density are linked to with aging associated decline (Stauber and
Muller, 2006; Chen et al., 2013).

samples. The normalization of sequencing depth across samples
and differential transposon expression analysis was performed
using edgeR (Robinson et al., 2010) with a ≥2-fold change in
expression and FDR 5%. The minimum expressed TE replicate
had to have a minimum of 10 reads among all samples after
normalizing for sequencing depth across samples.

Weighted Gene Co-expression Network
Analysis (WGCNA)
Weighted gene co-expression network analysis was performed
using the R package for transcriptome data following the
standard method described on the authors’ website (Langfelder
and Horvath, 2008). This unsupervised and unbiased analysis
identifies distinct co-expression gene modules by clustering
transcripts with similar expression patterns across samples.
Transcriptionally variable genes with an RPKM of ≥0.5 were
selected for the analysis. These genes were hierarchically clustered
based on a dissimilarity measure of topological overlap matrix.
The resulting dendrogram was used for module detection
(minimum size 100; height cutoff 0.23). Gene modules were
labeled in unique colors, with unassigned genes labeled in gray.
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